| 000 | 01726cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030836.0 | ||
| 008 | 130601s2013 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.18.Ph.D.2013.No.A | ||
| 100 | 0 | _aNoha Khalil Mohamed Khalil | |
| 245 | 1 | 0 |
_aAnti C1q antibodies in systemic lupus erythematosus / _cNoha Khalil Mohamed Khalil ; Supervised Aysha I. Z. Badawi , Mona Wassef , Sawsan Fadda |
| 246 | 1 | 5 | _aالأجسام المضادة للمكمل المناعى سي ١ كيو فى مرض الذئبة الحمراء الجهازى |
| 260 |
_aCairo : _bNoha Khalil Mohamed Khalil , _c2013 |
||
| 300 |
_a143 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
| 520 | _aSystemic lupus erythematosus (SLE) is a multifactorial disease its precise pathogenesis is unclear. There is growing evidence in favor of a clearance deficiency of apoptotic cells as the core mechanism in the pathogenesis of SLE. To assess the presence of anti-c1q antibodies in patient with SLE with and without activity, correlate the presence of these antibodies with lupus nephritis, and assess its predictive value for subsequent lupus nephritis | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAnti C1q antibodies | |
| 653 | 4 | _aLupus nephritis | |
| 653 | 4 | _aSLE | |
| 700 | 0 |
_aAysha Ibrahim Badawi , _eSupervisor |
|
| 700 | 0 |
_aMona Wassef , _eSupervisor |
|
| 700 | 0 |
_aSawsan Fadda , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c43076 _d43076 |
||